- Research article
- Open Access
- Open Peer Review
Evaluation of wound healing and anti-inflammatory activity of the rhizomes of Rumex abyssinicus J. (Polygonaceae) in mice
BMC Complementary and Alternative Medicine volume 15, Article number: 341 (2015)
Rumex abyssinicus Jacq (Polygonaceae) is widely used in Ethiopia for treatment of wound and other diseases. Although reports are available in the literature on some of the claimed activities, nothing has so far been reported about the wound healing activity of R. abyssinicus. Thus, this work was initiated to investigate the wound healing and anti-inflammatory activities of 80 % methanol extract of the rhizomes of R. abyssinicus in mice.
Following extraction of the rhizomes of the plant with 80 % methanol, the extract was formulated as ointment (5 % & 10 % w/w) with simple ointment base B.P. The ointment was then evaluated for wound healing activity using excision and incision wound models. Parameters, including wound contraction, epithelization time and hydroxyproline content were determined using the excision model, whereas tensile strength was measured from the incision model. In parallel, anti-inflammatory activity of the rhizome was evaluated with carrageenan induced hind paw edema model by dissolving the 80 % methanol extract in 1 % carboxyl methyl cellulose and administering orally in various doses (250, 500 and 750 mg/kg).
Wound treated with 5 % and 10 % (w/w) hydroalcoholic extract ointment exhibited significant wound healing activity in both models, as evidenced by increased wound contraction, shorter epithelization time, higher tissue breaking strength and increased hydroxyproline content. The hydroalcoholic extract also produced dose-related significant reduction (p < 0.05–0.001) of inflammation.
The results of this study demonstrated that the hydroalcoholic extract of the rhizomes of R. abyssinicus facilitated wound healing at least in part via its anti-inflammatory activity, supporting its traditional claim as a wound healing agent.
Wound may be described in different ways but the most common definition is “loss or breaking of cellular and anatomic or functional continuity of living tissues” [1, 2], and it can be broadly categorized as acute or chronic wound [3, 4]. The healing of wound is a complex process. At the time of injury, capillary will be damaged and blood clot is formed. This is followed by an early stage of inflammation. During the early phase of inflammation, cells like neutrophils and monocytes clean bacteria and necrotic tissue through phagocytosis as well as release of enzymes and toxic oxygen products. This is followed by migration of macrophage to wound area, which marks the transition from early to late phase of inflammation. The proliferative phase, which follows, is characterized by granulation and tissue proliferation formed mainly by fibroblast and the angiogenesis process. Finally, reformulation and improvement in the components of the collagen fiber that increases the tensile strength will occur during the remodeling stage . Thus, alterations in the inflammatory phase will impact the overall integrity of the healing wound.
Globally, wounds are a main cause of disability and lost productivity. Apart from the incidence, chronic wounds are known for causing different health problems. A study done in North European countries indicated that foot ulcers cause up to 85 % of amputations [5, 6]. In sub-Saharan African and South Asian countries, 1 % to 2 % of the population faces chronic wound at least once in their lifetime [7, 8]. More than 1.25 million people sustain burns and approximately 5 million suffer from non-healing wounds each year in the US . The cost of wound care is substantial. Chronic wounds cost European countries 1 % to 2 % of their annual health care budget and $1 billion/year in the US . This cost is unthinkable for most people in developing countries suffering from infected wounds . Indirect costs such as psychosocial damage and poor quality of life are also major concerns .
Majority of the population in both developing and some developed countries use traditional medicine for their primary health care [12, 13]. In developing countries, like Ethiopia, management of skin diseases and dermatological disorders such as cuts, wounds, and burns has relied on medicinal plants for a long period of time. Herbs are known to make the wounded area moist, which is very essential for healing [14, 15]. Nowadays, discovery is shifted towards wound healing promotion in order to reduce hospitalization cost and serious complications . Several lines of evidence have shown the benefits of a wide variety of plants in their wound healing capacity [2, 17]. Thus, plant products are considered to be the best and cost-effective substitutes for wound treatment.
Rumex abyssinicus Jacq (Family; Polygonaceae) is the most common traditional medicinal plant in the highlands of tropical Africa and distributed throughout North Africa and Ethiopia. In the Ethiopian traditional medicine, the rhizomes of R. abyssinicus (“Mekmeko” in Amharic) are used to treat malaria, gonorrhea, poisoning, hepatitis, constipation, sciatic neuralgia, hypertension, migraine, rheumatism, breast cancer, stomach distention, earache, liver diseases, hemorrhoids, typhus, rabies and wound [18–22].
Previous reports indicated that 80 % methanol extract of the rhizomes of R. abyssinicus possessed antimicrobial and in vitro anti-inflammatory activities , diuretic and analgesic , and antimalarial  activities. To date, however, no scientific report could be found in the literature concerning the wound healing activity of the plant, although there is an ample ethnobotanical claim for this property. This study was therefore conducted to provide scientific evidence for the folklore use of the plant in wound healing processes.
The fresh rhizomes of R. abyssinicus was collected from Menagesha forest, located 40 km west of Addis Ababa, Ethiopia. The plant was identified by a taxonomist and a voucher specimen (E001/10) was deposited at the National Herbarium, College of Natural and Computational Sciences, Addis Ababa University (AAU) for future reference.
Healthy, adult Swiss albino mice of either sex (25–30 g, and 6–8 weeks of age) purchased from the animal house of the Ethiopian Public Health Institute and adult Wistar rats of both sexes (200–300 g, aged 3–4 months) obtained from the animal house of the School of Pharmacy, AAU, were used for the study. The animals were housed in cages under standard conditions (25 ± 2 °C, 55 ± 5 % relative humidity, and 12 h light and dark cycles) and provided with pellet diet and water ad libitum. The study protocol was approved by the Ethics committee of the School of Pharmacy, AAU. Animal handling and care was carried out throughout the experiment following international laboratory animal use and care guidelines .
Rhizomes of R. abyssinicus were sliced to smaller pieces and dried for three weeks under shade. The dried rhizomes were then grinded to coarse powder. Five hundred gram of the powder was then macerated with 80 % methanol for three days in a conical flask with occasional stirring and shaking. The extract was then filtered (Whatman No. 1) and the residue was re-macerated twice to obtain maximum yield. The combined filtrate was then evaporated in a ventilated oven at 40 °C until dried. The resulting dry extract was weighed and provided a percentage yield of 16.2 % (w/w). The dried extract was stored in a refrigerator for the preparation of topical formulation (ointment).
Simple ointment of the 80 % methanol extract was prepared following the formula (Table 1) described in the British Pharmacopoeia . Three ointment preparations (each 200 g), with (5 % and 10 % w/w) and without (simple ointment only and served as a control) the extract were formulated using the reduced formula from the master formula (Table 1). All ingredients of the ointment base were mixed and heated gently, with stirring until homogenous and then stirred until cooled. For preparing medicated ointment, 10 g and 20 g of the 80 % methanol extract were mixed with 190 g and 180 g of the ointment base, respectively, by levigation on the surface of the ointment slab to make ointment of uniform consistency and smooth texture . In preparing the control ointment, 200 g of the base was taken and treated in the same manner to formulate ointment without an active ingredient.
Acute dermal toxicity
For dermal toxicity, a total of 10 (5 female and 5 male) rats were used. Animals showing normal skin texture were housed individually in a cage and acclimatized to the laboratory condition for five days prior to the test. Following acclimation, around 10 % of the body surface area fur was shaved 24 h before the study from the dorsal area of the trunk of the test animals. A limit test dose of 2000 mg/kg of the 10 % formulation was applied uniformly over the shaved area for 24 h. At the end of the exposure period, residual test substance was removed and the animals were observed for development of any adverse skin reactions daily for 14 days.
Grouping and dosing of animals
For excision model, four groups of mice, each containing six animals were used. The first group was treated with simple ointment, and served as a negative control. The second and third groups were treated with 5 % and 10 % of the extract ointment, respectively. The fourth group was treated with nitrofurazone (0.2 %) and served as a positive control. For incision model, five groups of mice, containing six mice per group were used. The animals of Group I-IV were treated in a similar fashion with excision wound model, but animals in Group V were not treated with any agents and served as untreated controls.
For assessment of anti-inflammatory activity, five groups of mice containing six animal per group were used. Group I was treated with 1 % carboxyl methyl cellulose (CMC) and served as a negative control. Groups II-IV were treated with 250 mg/kg, 500 mg/kg, and 750 mg/kg of the extract. Group V was treated with indomethacin (10 mg/kg). Dose levels were chosen based on acute oral toxicity results described elsewhere  and dose calculation was based on Deshmukh et al. , with slight modification. All administrations were performed orally, with a maximum volume of 10 ml/kg. The extract and the standard drug were dissolved in 1 % CMC to obtain an oral suspension.
Excision wound model
On wounding day, animals were anesthetized using subcutaneous injection of ketamine (1 ml/kg) and the back hair of the animals was depilated by shaving. About 300 mm2 circular area was then marked and the full thickness of the marked area was carefully excised by using sharp sterilized scissors. After 24 h of wound creation, the ointments were applied gently once daily, according to the respective grouping as described under grouping and dosing section, to cover the wounded area until complete healing was achieved. Wound contraction, epithelization period and hydroxyproline content were monitored. Wound contraction was measured as percent contraction every 2 days until complete wound closure was achieved .
Measurement of wound contraction
The wound healing progress was evaluated by measuring wound areas using a transparency sheet and a permanent marker. The evaluated surface area was used to calculate the percentage of wound contraction, taking initial size of the wound (300 mm2) as 100 %  as shown below:
Epithelization time measurement
The period of epithelization was calculated as the number of days required for falling off of the dead tissue remnants without any residual raw wound .
Estimation of hydroxyproline content
Following treatment with the formulations for 10 days of the circular wound created in the excision model, each animal from the respective group was killed on the 11th day using a high dose of anesthesia. The wound tissue was then excised and its weight was recorded and placed in 10 % formalin and stored in a refrigerator. On the day of the experiment, the tissue was dried in an oven at 60 °C for 12 h and the dry weight was again noted. The tissue was then hydrolyzed with 6 N HCl for 24 h at 110 °C in sealed glass tubes. The hydrolysate was neutralized to pH 7 . One ml of the supernatant solution was taken from each of the acid hydrolysate and treated in the same way to the standard hydroxyproline  and absorbance was determined at a wave length of 572 nm in 1 cm cell. The hydroxyproline content in each of sample solution was calculated using the equation which was obtained from the calibration curve (Fig. 1).
Incision wound model
On wounding day, animals were anesthetized in the same manner described for excision wound model. The dorsal fur of each mouse was then shaved and a 3 cm long longitudinal paravertebral incision was made through the skin and subcutaneous tissue. The parted skin was then sutured 1 cm apart using a surgical thread (no. 000) and curved needle (no. 11). The continuous thread on both wound edges was tightened for good closure of the wounds (Fig. 2a).
After 24 h of wound creation (on 1st day), animals were treated as described under grouping and dosing section, with topical formulation of vehicle, extract or standard daily for nine days, leaving out the last group which did not receive any of the interventions. The sutures were removed on day 8 post-incision and tensile strength was measured on the 10th post-wounding day using continuous water flow technique (Fig. 2b)  according to the formulas shown below .
Where so is simple ointment, and lu is left untreated.
Anti-inflammatory activity of R. abyssinicus was determined using mouse paw edema model. Following overnight fasting with free access to water, the basal volume of the right hind paw of each mouse was determined before administration of any drug using plethysmometer (Ugo Basile, Italy) . After determination of the basal volume, the animals were divided into five groups such that the mean volume of the different groups were similar. The mice were then treated as described under grouping and dosing section 1 h before carrageenan injection. Paw swelling was induced by subplantar injection of 0.05 ml of a solution of 1 % carrageenan in 0.9 % saline (w/v) into the right hind paw. The inflammation was quantified by measuring the volume displaced by the paw 1, 2, 3 and 4 h after carrageenan injection. Results were expressed as the paw volume (ml) variation with respect to the basal values. The percentage inhibition of edema for each group was calculated using the following formula :
Where Co is the average inflammation (hind paw edema) of the control group at a given time; and Ct is the average inflammation of the plant extract or indomethacin treated mice at the same time.
Raw data obtained from both wound and mouse paw edema models are expressed as mean ± SEM. The data were analyzed using SPSS version 17.0 and differences among groups were compared with one-way ANOVA followed by Post Hoc Tukey test. The data were considered significant at p < 0.05.
Acute dermal toxicity
Maximum concentration of the ointment (10 % (w/w)) administered at a limit dose of 2000 mg/kg was found to be safe. After 24 h of application of the ointment, the site did not show any sign of inflammation (Fig. 3). There were also no overt signs and symptoms observed when the animals were monitored for 48 h. Moreover, no signs of toxicity as well as no mortality were noted during the 14 days cage side observation.
Effect on excision wounds
Topical application of both 5 % and 10 % of the hydroalcoholic extract ointments in excision wound model significantly increased wound contraction rate compared to controls, with variable onset of action (Table 2 & Fig. 4). Whilst 5 % ointment produced a significant contraction on the 7th day (p < 0.01), 10 % produced on the 3rd day (p < 0.001). In addition, the contraction produced by the 10 % ointment was significantly greater (p < 0.01) than that of the 5 % on the 3rd and 5th day. No apparent difference was, however, observed thereafter between the two concentrations until the end of the observation period (Fig. 3). The 10 % ointment also appeared to provide better wound contraction than the reference compound until day 13, although the difference failed to reach statistical significance.
Table 3 shows epithelization period of excision wound of all formulations tested. Animals treated with the extract as well as the standard exhibited shorter epitthelization period than the controls. Time for epithelization was shorter by 23.1 % for 10 % (p < 0.001), 22.1 % for nitrofurazone (p < 0.001) and 16.3 % for 5 % (p < 0.05) compared to those treated with the ointment base. However, no apparent difference in epithelization period was found between the extract and the standard as well as between the different concentrations of the extract.
Estimation of hydroxyproline content
Hydroxyproline content of wound tissues following 10 days after treatment is depicted in Table 4. Hydroxyproline levels were significantly greater in animals treated with the extract as well as the standard compared to controls. Looking at the percentage increase, nitrofurazone achieved the maximum increase (102.2 %, p < 0.001) followed by 10 % (74.2 %, p < 0.001) and 5 % (31.6 %, p < 0.05) of the extract ointment. Once again, although there appeared to be a difference in mean increase values among the treatment, the difference did not reach statistical significance.
The mean tensile strength in the group treated with simple ointment base BP tended to increase by about 19.4 % compared to untreated controls, which failed to reach statistical significance. Tensile strength was, however, significantly increased by about 36.2 % (p < 0.05), 57.2 % (p < 0.001), and 79.1 % (p < 0.001) with 5 %, 10 % of the extract and nitrofurazone ointment, respectively, compared to controls treated with the ointment base (Table 5). The tensile strength of animals treated with the standard drug was significantly higher (p < 0.01) than the 5 % extract treated animals, although no apparent difference was detected with 10 % formulation of the extract.
Table 6 summarizes anti-inflammatory activity of the extract in mouse paw edema. Treatment with neither the extract nor the standard produced anti-inflammatory activity one hour following inflammation induction compared to controls. However, the two higher doses of the extract (500 and 750 mg/kg) as well as the standard drug significantly (p < 0.001) inhibited edema after 2 h of carrageenan injection. On the other hand, the lower dose (250 mg/kg) of the extract displayed anti-inflammatory activity (p < 0.05) after 3 h of edema induction.
Wound healing is a complex process that cannot be understood by using a single model or relying on an in vitro study. Better understanding of the healing process necessitates the use of two or more different in vivo models . Wound healing includes an acute inflammatory phase accompanied by collagen synthesis, which finally form a scar. Currently available drugs can’t affect all phases of wound healing, calling for the need for developing new drugs from different sources. Rapid healing requires fast wound contraction, shorter epithelization period and adequate gain of tensile strength. Biochemical markers, including tissue DNA, RNA, total protein, and hydroxyproline are indicative of better healing quality of drugs [37, 38]. Thus, in the present study, an attempt was made to evaluate the potential wound healing activity of R. abyssinicus, a medicinal plant used for wound healing in Ethiopian folklore medicine using the two most important wound models i.e., excision and incision wound models.
In excision wound model, the ointment formulated from the hydroalcoholic extract of the rhizomes of R. abyssinicus showed significant increase in percentage closure of excision wounds (Table 2 & Fig. 4). During the proliferative phase of wound healing, wound contraction enhances closure of the defect by pulling the edges of the wound towards the center . Contraction decreases healing time because it decreases the size of the wound and reduces the amount of extracellular matrix needed to repair the defect. Contraction also facilitates re-epithelization by shortening the distance migrating keratinocytes must travel . Moreover, the wound will close at fast rate, if the medication is more efficient . The effect of the rhizomes of R. abyssinicus on wound contraction points to the fact that the extract is endowed with pro-healing action as wound contraction accounts for 88 % of the healing process (the remaining healing is due to scar formation) . Although the mechanism by which the extract increased wound contraction remains to be seen, it is plausible to suggest that it might be attributed to either the plant’s anti-inflammatory effect (present study) or induction of macrophage cell proliferation .
In this study, the epithelization time was also found to be significantly shorter in animals treated with ointments containing the crude extract (Table 3). Epithelization involves the proliferation and migration of epithelial cells across the wound bed . Therefore, the shorter epithelization time in the hydroalcoholic extract might be due to facilitated proliferation of epithelial cells and/or increasing the viability of epithelial cells . A large body of evidence indicates that antimicrobial activity correlates with wound healing. Infection can seriously delay healing process by causing poor quality granulation tissue formation, reduced tensile strength of connective tissue, impaired epithelization and odor [14, 44]. Hence, increased rate of wound contraction and decrease in period of epithelization in the animals treated with the extract in excision wound model could also be attributed to the R. abyssinicus’s antimicrobial activity, as such activity is reported earlier for the plant . Wound re-epithelization is a hallmark of successful wound care . Moreover, better healing activity is distinguished with short epithelization period . Thus, shorter epithelializtion periods in animals treated with the extract reinforces the notion that R. abyssinicus has a potential application as a wound healing agent.
Hydroxyproline is an amino acid that is found in collagen and measuring its level indicates collagen turnover . The hydroxyproline content in mice treated with ointment containing the extract was significantly higher than controls, but comparable to the standard (Table 4). Higher hydroxyproline content in the extract and standard treated group might be related to enhancement of the proliferation and migration of fibroblasts and collagen deposition . Thus, it is conceivable to suggest that the observed decrease in epithelization and increase in wound contraction with application of the extract could be due to the plant’s potential to increase collagen synthesis through its effect on hydroxyproline content, as wound contraction begins almost concurrently with collagen synthesis .
Better efficacy of the crude extract in wound healing was further evidenced by the breaking strength in incision wounds (Table 5). Higher tensile strength is an indication of better wound healing  and it mainly depends on the increase in collagen concentration and stabilization of the fibers. Hence, based on the amount of hydroxyproline detected, it could be assumed that the crude extract enhanced the strength of the incision wound by increasing the collagen levels, which could stick the wound edges together at the repaired site .
Inflammation is important in wound healing. During acute wound it makes wound bed to be healed by removing necrotic tissue, debris, and bacterial contaminants as well as recruiting and activating fibroblasts. Under normal conditions, inflammation is a self-limiting process. Excessive inflammation, however, limits wound healing . The extract showed anti-inflammatory activity in carrageenan induced paw edema model in mice (Table 6). Carrageenan is widely used to induce hind paw edema for the discovery and evaluation of anti-inflammatory drugs . Carrageenan injection induces inflammation within short period of time. It produces three distinct phases: first (0–1.5 h), second (1.5–2.5 h) and third (2.5–5 h) phases of inflammation. The mediators of inflammation involved are histamine and serotonin, bradykinin, and prostaglandins for the three phases, respectively. The third phase is mostly used to assess anti-inflammatory effect of traditional medicinal plants, as this phase is sensitive to most clinically effective anti-inflammatory drugs . Neither of the treatments produced effect in the first hour, suggesting less responsiveness of phase one mediators to the tested agents (Table 5). Inhibition was, however, apparent following the 2nd hour, the only exception being 250 mg/kg of the extract. This observation could possibly indicate that phase 2 mediators’ response might vary with dose. On the other hand, all doses of the extract were effective from the 3rd hour onwards, regardless of the dose levels used, pointing to the fact that phase 3 mediators are the most likely targets for the extract. There appears also to be an in vitro and in vivo correlation, as in vitro anti-inflammatory activity for the plant has been described in previous reports . Moreover, this finding is concordant with earlier reports showing that plants having anti-inflammatory activity do also exhibit wound healing effect .
The 80 % methanol extract of the rhizomes of R. abyssinicus had been reported to possess secondary metabolites, including, among others, tannins, saponins, flavonoids, steroids and anthraquinones . Flavonoids and tannins have been shown to be important for wound healing due to their antioxidant, anti-inflammatory and antibacterial activities. In line with this notion, published reports indicate that hydroalcoholic extract of Rumex crispus , R. maderensis , R. acetosa, R. patientia , Polygonum convolvulus, Rheum undulatum, and R. acetosella  possess wound healing activity because of their phenolic (such as flavonoids and tannins) content. Active constituents such as chrysophanol, emodin and physcion were also previously isolated from the rhizomes of R. abyssinicus . Emodin [37, 56] and chrysophanol  isolated from other plant species are reported to have antimicrobial, anti-inflammatory and wound healing activities. In addition, majority of the Rumex species have also been reported to have antimicrobial action due to the presence of physcion and rumicin . Taken together, these findings collectively indicate that phytoconstituents individually or synergistically may initiate a host of mechanisms responsible for the wound healing activity of R. abyssinicus. Although histopathological studies are not performed that could have provided data with regeneration of the epithelium and disposal of the collagen, the measured parameters consistently showed that the plant is endowed with favorable wound healing activities. Preparations are underway to isolate the compound (s) responsible for the observed activities in subsequent studies.
The data generated from the present study indicated that the crude extract of the rhizomes R. abyssinicus increased wound contraction, breaking strength of the repaired tissue and hydroxylproline content. These findings highlight the potential wound healing activity of the plant and uphold the traditional claims of the plant for the treatment of wounds. The hydroalcoholic extract was also endowed with significant anti-inflammatory activities that explain, at least in part, its wound healing activity.
Pillai SI, Palsamy P, Subramanian S, Kandaswamy M. Wound healing properties of Indian propolis studied on excision wound induced rats. Pharm Biol. 2010;3:1–9.
Nagori BP, Solanki R. Role of medicinal plants in wound healing. Res J Med Plant. 2011;5(4):392–405.
Bowle PG. Wound pathophysiology, infection and therapeutic options. Ann Med. 2002;34:419–27.
Franz MG, Robson MC, Steed DL, Barbul A, Brem H, Cooper DM, et al. Guidelines to aid healing of acute wounds by decreasing impediments of healing. Wound Repair Regen. 2008;16:723–48.
Etufugh CN, Phillips TJ. Venous ulcers. Clin Dermatol. 2007;25:121–30.
Rathur HM, Boulton JM. The diabetic foot. Clin Dermatol. 2007;25:109–20.
Sasidharan S, Nilawatyi R, Xavier R, Latha LY, Amala R. Wound healing potential of Elaeis guineensis Jacq leaves in an infected albino rat model. Molecules. 2010;15:3186–99.
Siddiqui AR, Bernstein JM. Chronic wound infection: Facts and controversies. Clin Dermatol. 2010;28:519–26.
Meier K, Nanney LB. Emerging new drugs for wound repair. Expert Opin Emerg Drugs. 2006;11(1):23–37.
Pierce GF, Mustoe TA. Pharmacologic enhancement of wound healing. Annu Rev Med. 1995;46:467–81.
Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007;25:19–25.
Kokane DD, More RY, Kale MB, Nehete MN, Mehendale PC, Gadgoli CH. Evaluation of wound healing activity of root of Mimosa pudica. J Ethnopharmacol. 2009;124:311–5.
Robinson MM, Zhang X. The world medicines situation; Traditional medicines: Global situation, issues and challenges. Geneva, Switzerland: World Health Organization; 2011. p. 1–12.
Annan K, Houghton PJ. Antibacterial, antioxidant and fibroblast growth stimulation of aqueous extracts of Ficus asperifolia Miq. and Gossypium arboreum L., wound healing plants of Ghana. J Ethnopharmacol. 2008;119:141–4.
Patel JD, Shrivastava AK, Kumar V. Evaluation of some medicinal plants used in traditional wound healing preparations for antibacterial property against some pathogenic bacteria. J Clin Immunol Immunopathol Res. 2009;1(1):007–12.
James O, Victoria IA. Excision and incision wound healing potential of Saba florida (benth) leaf extract in rattus novergicus. Inter J Pharm Biomed Res. 2010;1(4):101–7.
Raina R, Prawez S, Verma PK, Pankaj NK. Medicinal plants and their role in wound healing. Vet Scan. 2008;3(1):1–7.
Teklehaymanot T, Giday M, Medhin G, Mekonnen Y. Knowledge and use of medicinal plants by people around Debre Libanos monastery in Ethiopia. J Ethnopharmacol. 2007;111:271–83.
Abebe D, Ayehu A. Medicinal plants and enigmatic health practices of Northern Ethiopia. Addis Ababa: Berhanina Selam Printing Enterprise; 1993. p. 247–60.
Abebe D, Debela A, Urga K. Medicinal plants and other useful plants of Ethiopia. Nairobi: Camerapix Publisher; 2003. p. 158–200.
Getie M, Gebre-Mariam T, Rietz R, Hohne C, Huschaka C, Schmdit M, et al. Evaluation of the antimicrobial and antiinflammatory activities of the medicinal plants Dodonea viscosa, Rumex nervosus, and Rumex abyssinicus. Fitototerapia. 2003;74:139–43.
Mekonnen T, Urga K, Engidawork E. Evaluation of the diuretic and analgesic activities of the rhizomes of Rumex abyssinicus J. in mice. J Ethnopharmacol. 2010;127:433–9.
Muganga R, Angenot L, Tits M, Frédérich M. Antiplasmodial and cytotoxic activities of Rwandan medicinal plants used in the treatment of malaria. J Ethnopharmacol. 2010;128(1):52–7.
Institute for Laboratory Animal Research (ILAR). Guide for the care and use of laboratory animals. Washington D.C: National Academy Press; 1996.
British Pharmacopoeia. Department of health and social security Scottish home and health department. 2nd ed. UK: Office of the British Pharmacopoeia commission; 1988. p. 713.
Ansel HC. Introduction to pharmaceutical dosage forms. 4th ed. Philadelphia: Lea and Febiger; 1985. p. 299–301.
Deshmukh PT, Fernandes J, Atul A, Toppoa E. Wound healing activity of Calotropis gigantea root bark in rats. J Ethnopharmacol. 2009;125:178–81.
Shivhare Y, Singour PK, Patil UK, Pawar RS. Wound healing potential of methanolic extract of Trichosanthes dioica Roxb (fruits) in rats. J Ethnopharmacol. 2010;127:614–9.
Wesley JJ, Christina AJM, Chidambaranathan N, Ravikumar K. Wound healing activity of the leaves of Tribulus terrestris (linn) aqueous extract in rats. J Pharm Res. 2009;2(5):841–3.
Sanwal R, Chaudhary AK. Wound healing and antimicrobial potential of Carissa spinarum Linn. in albino mice. J Ethnopharmacol. 2011;135:792–6.
Leach AA. Notes on a modification of the Neuman and Logan method for the determination of hydroxyproline. 74th ed. London: The British Gelatin and Glue Research Association; 1960. p. 70–1.
Wang J, Ruana J, Caia Y, Luob Q, Xuc H, Wua Y. In vitro and in vivo evaluation of the wound healing properties of Siegesbeckia pubescens. J Ethnopharmacol. 2011;134:1033–8.
Akkol EK, Süntar I, Orhan IE, Keles H, Kanc A, Çoksari G. Assessment of dermal wound healing and in vitro antioxidant properties of Avena sativa L. J Cereal Sci. 2011;53:285–90.
Padilha MM, Vilela FC, Rocha CQ. Anti-inflammatory properties of Morus nigra leaves. Phytother Res. 2010;24:1496–500.
Mahomed IM, Ojewole JAO. Analgesic, anti-inflammatory and anti-diabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother Res. 2004;18:982–9.
Abdulla MA, Ahmed KA, Abu-Luhoom FM, Muhanid M. Role of Ficus deltoidea extract in the enhancement of wound healing in experimental rats. Biomed Res. 2010;21(3):241–5.
Kanti BT, Biswajit A, Nitai P. Wound healing activity of human placental extracts in rats. Acta Pharmacol Sin. 2001;22(12):1113–6.
Paschapur MS, Patil MB, Kumar R, Patil SR. Evaluation of aqueous extract of leaves of Ocimum kilimandscharicum on wound healing activity in albino wistar rats. Inter J PharmTech Res. 2009;1(3):544–50.
Tang T, Yin L, Yang J, Shan G. Emodin, an anthraquinone derivative from Rheum officinale baill, enhances cutaneous wound healing in rats. Eur J Pharmacol. 2007;567:177–85.
Strodtbeck F. Physiology of wound healing. Newborn Infant Nurs Rev. 2001;1:43–52.
Prasad V, Dorle AK. Evaluation of ghee based formulation for wound healing activity. J Ethnopharmacol. 2006;107:38–47.
Ejaz S, Chekarova I, Cho JW, Lee SY, Ashraf S, Lim CW. Effect of aged garlic extract on wound healing: A new frontier in wound management. Drug Chem Toxicol. 2009;32(3):191–203.
Esimone C, Nworu C, Jackson C. Cutaneous wound healing activity of a herbal ointment containing the leaf extract of Jatropha curcas L. (Euphorbiaceae). Inter J Appl Res in Nat Prod. 2008;1:1–4.
OECD: Acute dermal toxicity. Guidelines for testing of chemicals, 1987, February. 402, 1–7. http://www.keepeek.com/Digital-Asset-Management/oecd/environment/test-no-402-acute-dermal-toxicity_9789264070585-en#page1
Stadelmann W, Digenis A, Tobin G, Louisville K. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998;176:26S–38S.
Süntar IP, Akkol EK, Yilmazer D, Baykal T, Kirmizibekmez H, Alper M, et al. Investigations on the in vivo wound healing potential of Hypericum perforatum L. J Ethnopharmacol. 2010;127:468–77.
Nayak S, Nalabothu P, Sandiford S, Bhogadi V, Adogwa A. Evaluation of wound healing activity of Allamanda cathartica. L. and Laurus nobilis. L. extracts in rats. BMC Complement Altern Med. 2006;6(12):1–6.
Hayouni E, Miled K, Boubaker S, Bellasfar Z, Abedrabba M, Iwaski H, et al. Hydroalcoholic extract based ointment from Punica granatum L. peels with enhanced in vivo healing potential on dermal wounds. Phytomedicine. 2011;18:976–84.
Swamy H, Krishna V, Shankarmurthy K, Rahiman B, Mankani K, Mahadevan K, et al. Wound healing activity of embelin isolated from the ethanol extract of leaves of Embelia ribes Burm. J Ethnopharmacol. 2007;109:529–34.
Marrassini C, Acevedo C, Miño J, Ferraro G, Gorzalczany S. Evaluation of antinociceptive, antiinflammatory activities and phytochemical analysis of aerial parts of Urtica urens L. Phytother Res. 2010;24:1807–12.
Coruh I, Gormez AA, Ercisli S, Sengul M. Total phenolic content, antioxidant, and antibacterial activity of Rumex crispus grown wild in Turkey. Pharm Biol. 2008;46(9):634–8.
Tavares L, Carrilho D, Tyagi M. Antioxidant capacity of macaronesian traditional medicinal plants. Molecules. 2010;15:2576–92.
Sreelekshimi R, Latha PG, Shyamal S. Anti-inflammatory, analgesic and anti-lipid peroxidation studies on stem bark of Ficuss religiosa Linn. Nat Prod Radiance. 2007;6(5):377–81.
Tseye-Oidov O, Mikami I, Watanabe J. Antioxidant capacities and total quercetin content of several species of polygonaceae in Mongolia. Food Sci Technol Res. 2010;16(2):169–74.
Fassil Y, Bezabeh A, Abegaz B. Anthracene derivatives from Rumex abyssinicus. J Nat Prod. 1984;48(1):148–55.
Omoregie EH, Anselem O, Sabo A, Koma OS, Ibumeh J. Phytochemical analysis and broad spectrum antimicrobial activity of Cassia occidentalis L. (whole plant). New York Sci J. 2010;3(10):74–81.
Kim S, Kim M, Lee B, Park D, Hong S, Um J. Anti-inflammatory activity of chrysophanol through the suppression of NF-κB/Caspase-1 activation in vitro and in vivo. Molecules. 2010;15:6436–51.
The authors would like to thank Addis Ababa University for the financial support extended to complete the research work.
The authors declare that they have no competing interests.
Study concept and design: EM, KA and EE. Data collection: EM. Statistical analysis: EM, KA and EE. Analysis and interpretation of data: EM, KA and EE. Drafting of the manuscript: EM. Critical revision of the manuscript for important intellectual content: KA and EE. Study supervision: KA and EE. All authors read and approved the final manuscript.
About this article
Cite this article
Mulisa, E., Asres, K. & Engidawork, E. Evaluation of wound healing and anti-inflammatory activity of the rhizomes of Rumex abyssinicus J. (Polygonaceae) in mice. BMC Complement Altern Med 15, 341 (2015) doi:10.1186/s12906-015-0878-y
- Rumex abyssinicus
- Excision model
- Incision model
- Wound healing